Common Contracts
3 similar Credit Agreement contracts by Indivior PLC, Syneos Health, Inc.
CREDIT AGREEMENT Dated as of December 19, 2014 as amended as of March 16, 2015 as further amended as of December 18, 2017 as further amended as of June 30, 2021 and as further amended as of April 27, 2022 among INDIVIOR FINANCE S.À R.L., as a Term...Credit Agreement • May 23rd, 2023 • Indivior PLC • Pharmaceutical preparations • New York
CREDIT AGREEMENT, dated as of December 19, 2014 and as amended as of March 16, 2015, as further amended as of December 18, 2017 and as further amended as of June 30, 2021 (this “Agreement”), by and among Indivior Finance S.à r.l., a private limited liability company (société à responsabilité limitée) incorporated under the laws of the Grand Duchy of Luxembourg, having its registered office at 21, rue de Fort Elisabeth, L-1463 Luxembourg, Grand Duchy of Luxembourg, registered with the Luxembourg Trade and Companies Register (R.C.S. Luxembourg) under number B 191.812 (the “Lux Borrower”), Indivior SMTM LLC, a limited liability company organized under the laws of Delaware (the “US Co-Borrower”), RBP Global Holdings Limited, a limited company organized under the laws of England and Wales (the “Borrower Representative” or the “Revolver Borrower”, and together with the Term Borrowers (as defined below), the “Borrowers” and each a “Borrower”), the other Loan Parties from time to time party he
CREDIT AGREEMENT Dated as of December 19, 2014 as amended as of March 16, 2015 as further amended as of December 18, 2017 as further amended as of June 30, 2021 and as further amended as of April 27, 2022 among INDIVIOR FINANCE S.À R.L., as a Term...Credit Agreement • November 22nd, 2022 • Indivior PLC • Pharmaceutical preparations • New York
CREDIT AGREEMENT, dated as of December 19, 2014 and as amended as of March 16, 2015, as further amended as of December 18, 2017 and as further amended as of June 30, 2021 (this “Agreement”), by and among Indivior Finance S.à r.l., a private limited liability company (société à responsabilité limitée) incorporated under the laws of the Grand Duchy of Luxembourg, having its registered office at 21, rue de Fort Elisabeth, L-1463 Luxembourg, Grand Duchy of Luxembourg, registered with the Luxembourg Trade and Companies Register (R.C.S. Luxembourg) under number B 191.812 (the “Lux Borrower”), Indivior SMTM LLC, a limited liability company organized under the laws of Delaware (the “US Co-Borrower”), RBP Global Holdings Limited, a limited company organized under the laws of England and Wales (the “Borrower Representative” or the “Revolver Borrower”, and together with the Term Borrowers (as defined below), the “Borrowers” and each a “Borrower”), the other Loan Parties from time to time party he
AMENDMENT NO. 5Credit Agreement • July 1st, 2021 • Syneos Health, Inc. • Services-commercial physical & biological research • New York
CREDIT AGREEMENT, dated as of August 1, 2017 (this “Agreement”), by and among Syneos Health, Inc. (f/k/a INC Research Holdings, Inc.), a Delaware corporation (“INC Holdings” or the “Administrative Borrower”), the entities listed on Schedule I hereto (each a “Borrower” and collectively with the Administrative Borrower, the “Borrowers”), the Lenders from time to time party hereto, JPMorgan Chase Bank, N.A. (as successor to Credit Suisse AG, Cayman Islands Branch (“Credit Suisse”)), as administrative agent and collateral agent for the Lenders (in such capacities, the “Administrative Agent”), and ING Capital LLC (“ING”), Goldman Sachs Bank USA, BofA Securities, Inc. Morgan Stanley Senior Funding, Inc., Citibank, N.A., Fifth Third Bank, National Association, JPMorgan Chase Bank, N.A., PNC Capital Markets LLC, Regions Capital Markets, a Division of Regions Bank, MUFG Bank, Ltd. and Wells Fargo Securities, LLC, Truist Securities, Inc., Keybank National Association and TD Securities (USA) LLC,
